Metelimumab Antibody
Metelimumab (CAT-192) is a humanized monoclonal antibody designed to neutralize TGFβ1. It serves as a key research tool for investigating the pathogenesis and potential treatment strategies for diffuse systemic sclerosis (d-SSc) in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
CAT192, CAT-192, Anti-TGFB1 Recombinant Antibody
Target
TGF-beta/Smad
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Concentration
15.745 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-3192R-RBITC-TR 20 µL
Phospho-IRAK1 (Ser376) Polyclonal Antibody, RBITC Conjugated
Sign In for Pricing
View Details HY-P78931-01 25 µg
ASGR1/ASGPR1, Human (Biotinylated, HEK293, His-Avi)
Sign In for Pricing
View Details HY-P78931-02 200 µg
ASGR1/ASGPR1, Human (Biotinylated, HEK293, His-Avi)
Sign In for Pricing
View Details 
RC207703L3V 200 µL
Netrin 5 (NTN5) (NM_145807) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details